Brain Tumour Research Review

Professor Oliver Hanemann

Chair

Professor Oliver Hanemann is a clinical academic and has led the Brain Tumour Research Centre of Excellence funded by Brain Tumour Research in Plymouth for many years. Professor Hanemann has a long track record in Neuro-oncology including many fruitful collaborations, such as part of the ICOM or REiNS consortium.  

As a member of the scientific board of EANO and WFNOS and in grant review panels (e.g. Brain Research UK), Professor Hanemann has an insight into challenges faced in brain tumour research. 

Dr Lucy Stead

Deputy Chair

Dr Lucy Stead is an Associate Professor in Brain Cancer Research at The University of Leeds, and a UKRI Future Leaders Fellow.

As a computational biologist, she runs a hybrid research group of bioinformaticians and experimentalists, all focused on understanding why glioblastoma brain tumours recur following standard treatment. The group performs large scale molecular profiling of longitudinal patient tumours to characterise tumour heterogeneity and identify drivers of therapy-driven evolution and adaption. They then use a range of state-of-the-art glioma models to better understand which driver events are therapeutically targetable, and may lead to drugs to be combined with current standard of care to stop tumour recurrence.

Dr Karin Purshouse

Early Career Researcher (ECR) Lead

Dr Karin Purshouse is an ECAT Clinical Lecturer and Honorary Registrar in Medical Oncology in Edinburgh. She is currently a PhD student studying extrachromosomal DNA in glioblastoma at the University of Edinburgh, and her interests include translational research and clinical trials.